MetaVia Inc. MetaVia Inc.

MetaVia Inc.

MTVA

Pozycja w akcjach #32908
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a... Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
Cena akcji
$1.28
Kapitalizacja rynkowa
$8.43M
Zmiana (1 dzień)
4.07%
Zmiana (1 rok)
-21.47%
Kraj
US
Handel MetaVia Inc. (MTVA)

Kategoria

Healthcare
Historia podziałów akcji dla MetaVia Inc. (MTVA)
Akcje MetaVia Inc. (symbol: MTVA) przeszły łącznie 3 podziałów.
Najnowszy podział miał miejsce Dec 21, 2023.
Jedna akcja MTVA kupiona przed Dec 31, 2019 odpowiada dziś 0.00016666666666667 akcjom MTVA.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
2023-12-21 1:8 x0.125 x0.00016666666666667
2022-09-13 1:30 x0.033333333333333 x0.0013333333333333
2019-12-31 1:25 x0.04 x0.04
Podziały akcji dla podobnych firm lub konkurencji
Firma Liczba podziałów akcji Skumulowany mnożnik Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL